MedImmune

AstraZeneca unit loses patent rights
FT.com
Wed, 07/6/11 - 08:17 am
AstraZeneca
patents
Roche
MedImmune
ranibizumab
Novartis
PDL Settles MedImmune Dispute
Yahoo/Zacks.com
Fri, 02/18/11 - 03:17 pm
PDL Biopharma
MedImmune
AstraZeneca
RSV
Synagis
Abbott Laboratories
PDLI's Synagis Lawsuit Invalidated
Yahoo/Zacks.com
Tue, 01/11/11 - 02:37 pm
Synagis
PDL Biopharma
MedImmune
lawsuits
Abbott Laboratories
MedImmune inks $342M collaboration on diabetes program
Fierce Biotech
Thu, 12/16/10 - 01:11 pm
MedImmune
diabetes
Evotec
Pharma Mergers Scrutinized In Insider Trading Probe
Reuters
Fri, 12/3/10 - 08:24 am
M&A
insider trading
MedImmune
AstraZeneca
Wyeth
Pfizer
Merck
Schering Plough
Biotech Ends October With Almost $1B in IPOs, $3B in M&A Activity, $3B in Possible Partnerships
Seeking Alpha
Sun, 10/31/10 - 11:35 am
Teva Pharmaceuticals
Sanofi
Pfizer
Pacific Biosciences
Merck
Macrogenics
Hikma
GSK
BMP Sunstone
biotech
Baxter International
Amicus Therapeutics
Immune Design
MedImmune
Good News for Micromet
Yahoo/Zacks.com
Wed, 10/13/10 - 12:12 pm
Micromet
MedImmune
AstraZeneca
MedImmune Bets Its Fate on “Biobetters”
PharmExec
Fri, 09/10/10 - 11:21 am
MedImmune
AstraZeneca
biosimilars
Red Signal for AstraZeneca Drug
Yahoo/Zacks.com
Mon, 09/6/10 - 10:01 am
AstraZeneca
MedImmune
RSV
motavizumab
Synagis' Special Status Under Health Care Reform
InVivo
Tue, 08/24/10 - 07:23 am
RSV
MedImmune
Synagis
AstraZeneca
Cornerstone buys back technology from MedImmune
Yahoo/AP
Tue, 07/6/10 - 10:46 am
Cornerstone Therapeutics
MedImmune
FDA Resets Motavizumab Decision to Aug. 27
TopWireNews
Sat, 06/26/10 - 10:50 am
motavizumab
RSV
MedImmune
AstraZeneca
FDA Committee Votes to Reject AstraZeneca RSV Drug: Biotech's Latest Mishaps
Seeking Alpha
Sun, 06/6/10 - 11:03 am
RSV
AstraZeneca
MedImmune
motavizumab
Axanum
FDA panel rejects AZ's new RSV drug in key setback
Fierce Biotech
Thu, 06/3/10 - 10:07 am
RSV
motavizumab
MedImmune
FDA
AstraZeneca
FDA Panel Recommends Single Flu Vaccine
WSJ Online
Mon, 02/22/10 - 03:33 pm
FDA
vaccines
H1N1
Flu
GSK
Novartis
Sanofi
CSL
MedImmune
AstraZeneca still waiting for the upside to MedImmune acquisition
Bizjournals.com
Fri, 02/5/10 - 10:31 am
MedImmune
AstraZeneca
M&A
Pivotal Trial Results for Motavizumab Published in Current Issue of 'Pediatrics'
Yahoo/PR NewsWire
Sat, 01/30/10 - 11:11 am
MedImmune
motavizumab
RSV
MedImmune responds to FDA on pediatric drug
Bizjournals.com
Mon, 12/28/09 - 04:42 am
FDA
MedImmune
Synagis
RSV
MedImmune licenses RSV antibodies in $338M deal
Fierce Biotech
Tue, 12/1/09 - 10:25 am
RSV
antibodies
MedImmune
liscensing
Trellis Biosciences
Micromet takes back MedImmune's blinatumomab rights
Fierce Biotech
Fri, 11/6/09 - 10:46 am
MedImmune
blinatumomab
Micromet

Pages